Kate Bingham co-leads SV's biotech franchise, investing in drug discovery and development companies. She was awarded a DBE in 2021 for chairing the UK Vaccine Taskforce.








At firms with a similar stage, sector and check size.





One email when Kate's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckKate Bingham co-leads SV's biotech franchise, investing in drug discovery and development companies. She was awarded a DBE in 2021 for chairing the UK Vaccine Taskforce.
SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder SV Health Investors backed works best.
Chair at UK Vaccine Taskforce.
Last updated 2026-10-15. Is this you? Ask for a correction.